Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell (Q39626464)

13 September 2017

Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell (English)

1 reference

13 September 2017

0 references

Mingxia Zhang

1

1 reference

13 September 2017

Gucheng Zeng

2

1 reference

13 September 2017

Qianting Yang

3

1 reference

13 September 2017

Jieyun Zhang

4

1 reference

13 September 2017

Xiuyun Zhu

5

1 reference

13 September 2017

Qi Chen

6

1 reference

13 September 2017

Pichaimuthu Suthakaran

7

1 reference

13 September 2017

Ying Zhang

8

1 reference

13 September 2017

Qunyi Deng

9

1 reference

13 September 2017

Haiying Liu

10

1 reference

13 September 2017

Boping Zhou

11

1 reference

13 September 2017

Xinchun Chen

12

1 reference

13 September 2017

20 December 2013

1 reference

13 September 2017

1 reference

13 September 2017

94

1 reference

13 September 2017

3

1 reference

13 September 2017

238-244

1 reference

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Human T cells induce their own regulation through activation of B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Regulation of immunity and autoimmunity by B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Restoration of mycobacterial antigen-induced proliferation and interferon-Î³ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Multifunctional CD4 T cell responses in patients with active tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.12.003

10.1016/J.TUBE.2013.12.003

7 January 2021

Identifiers

DOI

1 reference

release_z3f64mbvnjer3ge4rgnyygksbu

13 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z3f64mbvnjer3ge4rgnyygksbu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference